InsidersTradesSigma
엘앤씨바이오 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 엘앤씨바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 엘앤씨바이오 has logged 74 insider filings. Market capitalisation: €1,182.7bn. The latest transaction was filed on 30 April 2026 (Sale). Among the most active insiders: 이환철. Every trade is openly available.
74
Insider Decl.
n/a
Thresholds
€111,132
45 ops.
Buy Volume
n/a
14 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,714 of 27,982 companies
32.4
score / 100
Value26
Quality39
FCF yld-0.4%
Earn yld-12%
EV/EBITDA·
ROE-53%
Gross mgn53%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 April 2026
Declarations74 total
1,253,131 sharesKRXDART:20250710000520
501,254 sharesKRXDART:20250610000363
25 of 74 declarations
About 엘앤씨바이오
엘앤씨바이오 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical products.